Analgesic drug using PAC1 receptor antagonistic drug
This invention relates to an analgesic drug comprising a compound represented by the following formula (I) or (II), wherein R 1 is a C 1-6 -alkoxy group or a C 1-6 -haloalkoxy group; R 2 is a hydrogen atom; and R is an indazolyl group substituted with a halogen atom; a substituted or unsubstituted phenyl group; a pyrazolyl group; or a substituted or unsubstituted aralkyl group; or a salt thereof, or a solvate thereof.
1. A compound represented by the following formula (I),
wherein R 1 is a C 1-6 -haloalkoxy group; and R 2 is a hydrogen atom; or a salt thereof, or a solvate thereof.
2. The compound according to claim 1 or a salt thereof, or a solvate thereof, wherein R 1 is a trifluoromethoxy group in the formula (I).
3. An analgesic drug comprising a compound according to claim 1 , a salt thereof, or a solvate thereof.